IMS Health has acquired TTC, a benchmarking solutions and analytics company for the life sciences that helps plan and negotiate clinical trial costs. TTC offers a set of clinical trial cost benchmarks, budgeting and negotiation tools aimed at enhancing the speed, efficiency and cost-effectiveness of trial planning and management activities.   IMS will integrate its evidence-based, patient and treatment outcomes insights with TTC’s cost data drawn from organizations that conduct nearly 80% of all...